4.6 Article

Nonionic detergent micelle aggregates: An economical alternative to protein A chromatography

期刊

NEW BIOTECHNOLOGY
卷 61, 期 -, 页码 90-98

出版社

ELSEVIER
DOI: 10.1016/j.nbt.2020.11.013

关键词

Antibody purification; Protein A; Separation; Micelles

资金

  1. Kimmelman Center for Biomolecular Structure and Assembly
  2. Benoziyo Endowment Fund for the Advancement of Science
  3. Ariel University

向作者/读者索取更多资源

The study demonstrates that a non-chromatographic, ligand-free approach using detergent aggregates can effectively purify antibodies, with varying efficacy observed for different types of detergents. Furthermore, the purification method allows for continuous purification mode through filtration, achieving high recovery rates and preservation of Ab specificity.
We have recently described a non-chromatographic, ligand-free approach for antibody (Ab) purification based on specially designed [Tween-20:bathophenanthroline:Fe2+] aggregates. To assess the potential generality of this approach, a variety of detergents belonging to four nonionic detergent families (Tween, Brij, Triton and Pluronic) have now been studied. All surfactant aggregates led to high purity of the recovered Ab's (>95 %, by gel densitometry). Good overall Ab recovery yields were observed with Tween-20 (80-83 %), Brij-O20 (85-87 %) and Triton X-100 (87-90 %), while Pluronic F-127 was less efficient (42-53 %). Of additional importance is the finding that the process was performed by filtration rather than centrifugation, thereby allowing a continuous purification mode that led to the recovery of monomeric IgG, as determined by dynamic light scattering and preservation of Ab specificity as measured by ELISA. The amphiphilic chelator, bathophenanthroline (batho) was recycled almost quantitatively (95 %) by crystallization. Good IgG recovery yields of similar to 80 % were also observed when Ab concentrations were increased from 1 mg/mL to 3-5 mg/mL. Potential advantages of the purification platform for industrial downstream processing of therapeutic monoclonal antibodies, are discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据